CALCIMEDICA, INC.

Profile

Company Names

CALCIMEDICA, INC.
GRAYBUG, INC.
GRAYBUG VISION, INC.
GRAYBUG LLC

Addresses

505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA 92037

275 SHORELINE DRIVE, SUITE 450, REDWOOD CITY, CA 94065

303 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY, CA 94065-1422

6411 BECKLEY STREET, BALTIMORE, MD 21224

855 N. WOLFE STREET, GROUND FLOOR SUITE B, BALTIMORE, MD 21205

400 NORTH BROADWAY, STE 6013, BALTIMORE, MD 21231

35 WARRENTON ROAD, BALTIMORE, MD 21210

1340 SMITH AVENUE, SUITE 200, BALTIMORE, MD 21209

Phone Numbers

858-952-5500
443-853-2377
650-487-2800
410-614-9852
410-779-1236

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

MARYLAND

Total Amount Raised:

$144,808,735.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2023-03-20 
$9,109,912.00 
$9,109,912.00 
$0.00 
Equity 
7
2019-07-31 
$54,999,994.00 
$79,999,992.00 
$24,999,998.00 
Equity 
6
2016-04-29 
$75,393,829.00 
$80,393,829.00 
$5,000,000.00 
Equity 
5
2015-12-11 
$750,000.00 
$1,000,000.00 
$250,000.00 
Debt 
4
2015-02-19 
$1,740,000.00 
$1,740,000.00 
$0.00 
Equity 
3
2014-08-21 
$750,000.00 
$1,325,000.00 
$575,000.00 
Equity 
2
2013-09-03 
$1,455,000.00 
$2,000,000.00 
$545,000.00 
Equity 
1
2011-10-24 
$610,000.00 
$1,000,000.00 
$390,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERIC 
 
BJERKHOLT 
DIRECTOR
GERALD 
 
CAGLE, PH.D. 
DIRECTOR
JEFFREY 
 
CLELAND 
DIRECTOR, EXECUTIVE OFFICER
JEFFREY 
L. 
CLELAND 
EXECUTIVE OFFICER, DIRECTOR
EMMETT 
 
CUNNINGHAM 
DIRECTOR
EMMETT 
 
CUNNINGHAM, M.D., PH.D. 
DIRECTOR
MICHAEL 
J. 
DUNN 
EXECUTIVE OFFICER
FREDERIC 
 
GUERARD 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JUSTIN 
 
HANES 
DIRECTOR, EXECUTIVE OFFICER
SUDARSHAN 
 
HEBBAR 
EXECUTIVE OFFICER
HANSOO 
MICHAEL 
KEYOUNG 
DIRECTOR
CHAU 
 
KHOUNG 
DIRECTOR
A. 
RACHEL 
LEHENY 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
O-ROURKE 
EXECUTIVE OFFICER, DIRECTOR
ERIC 
W. 
ROBERTS 
EXECUTIVE OFFICER, DIRECTOR
CHRISTY 
 
SHAFFER, PH.D. 
DIRECTOR
ALLAN 
 
SHAW 
DIRECTOR
KENNETH 
A. 
STAUDERMAN 
EXECUTIVE OFFICER
PAMELA 
 
WAPNICK 
EXECUTIVE OFFICER, PROMOTER
CAMERON 
 
WHEELER, PH.D. 
DIRECTOR
ROBERT 
N. 
WILSON 
DIRECTOR
CHRISTY 
 
WYSKIEL 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-19 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2014-08-21 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-09-03 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-09-03 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-10-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE